Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1

Z. Prohászka, T. Hidvegi, E. Újhelyi, H. Stoiber, M. P. Dierich, C. Susal, G. Füst

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Previously we have investigated the interaction of human complement as well as one polyclonal and three human monoclonal antibody preparations with the human immunodeficiency virus type-1 (HIV-1) transmembrane recombinant glycoprotein (rgp41). A strong competition was found between the antibodies and deposited complement proteins for the same binding sites located within the immunodominant region of rgp41. The aim of the present experiments was to see if the same type of antibody-complement-HIV-1 interactions could be observed with the outer envelope glycoprotein (rgp 120) of HIV-1. Three different glycosylated rgp 120 preparations, as well as a synthetic peptide corresponding to the V3 loop of the MN strain, were adsorbed to enzyme-linked immunosorbent assay (ELISA) plates and incubated with mixtures of anti-rgp120 antibodies and normal human serum (NHS) as a complement source. Fixed complement proteins and antibodies were detected with specific, peroxidase-labelled antibodies against different complement proteins (C1q, C4b, C3b) and the γ-chain of antibodies. In the absence of anti-rgp120, high amounts of C3 were deposited to each rgp120 preparation tested (including the V3 peptide) but significant differences in the amounts of bound C1q and C4b were observed. Using sera deficient in different complement proteins, we found that both the classical and the alternative pathways contributed to the C3 binding to rgp120. Addition of specific antibodies did not increase complement activation by rgp120 and only in the case of a monoclonal antibody to the V3-loop could we see complement-dependent inhibition of antibody binding.

Original languageEnglish
Pages (from-to)184-189
Number of pages6
JournalImmunology
Volume85
Issue number2
Publication statusPublished - 1995

Fingerprint

HIV-1
Glycoproteins
Antibodies
Complement System Proteins
Complement C1q
Monoclonal Antibodies
Immunodominant Epitopes
Peptides
Complement Activation
Serum
Protein Binding
Peroxidase
Anti-Idiotypic Antibodies
Enzyme-Linked Immunosorbent Assay
Binding Sites

ASJC Scopus subject areas

  • Immunology

Cite this

Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. / Prohászka, Z.; Hidvegi, T.; Újhelyi, E.; Stoiber, H.; Dierich, M. P.; Susal, C.; Füst, G.

In: Immunology, Vol. 85, No. 2, 1995, p. 184-189.

Research output: Contribution to journalArticle

Prohászka, Z. ; Hidvegi, T. ; Újhelyi, E. ; Stoiber, H. ; Dierich, M. P. ; Susal, C. ; Füst, G. / Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. In: Immunology. 1995 ; Vol. 85, No. 2. pp. 184-189.
@article{7af01fb341ce43648e9221377cd332ac,
title = "Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1",
abstract = "Previously we have investigated the interaction of human complement as well as one polyclonal and three human monoclonal antibody preparations with the human immunodeficiency virus type-1 (HIV-1) transmembrane recombinant glycoprotein (rgp41). A strong competition was found between the antibodies and deposited complement proteins for the same binding sites located within the immunodominant region of rgp41. The aim of the present experiments was to see if the same type of antibody-complement-HIV-1 interactions could be observed with the outer envelope glycoprotein (rgp 120) of HIV-1. Three different glycosylated rgp 120 preparations, as well as a synthetic peptide corresponding to the V3 loop of the MN strain, were adsorbed to enzyme-linked immunosorbent assay (ELISA) plates and incubated with mixtures of anti-rgp120 antibodies and normal human serum (NHS) as a complement source. Fixed complement proteins and antibodies were detected with specific, peroxidase-labelled antibodies against different complement proteins (C1q, C4b, C3b) and the γ-chain of antibodies. In the absence of anti-rgp120, high amounts of C3 were deposited to each rgp120 preparation tested (including the V3 peptide) but significant differences in the amounts of bound C1q and C4b were observed. Using sera deficient in different complement proteins, we found that both the classical and the alternative pathways contributed to the C3 binding to rgp120. Addition of specific antibodies did not increase complement activation by rgp120 and only in the case of a monoclonal antibody to the V3-loop could we see complement-dependent inhibition of antibody binding.",
author = "Z. Proh{\'a}szka and T. Hidvegi and E. {\'U}jhelyi and H. Stoiber and Dierich, {M. P.} and C. Susal and G. F{\"u}st",
year = "1995",
language = "English",
volume = "85",
pages = "184--189",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1

AU - Prohászka, Z.

AU - Hidvegi, T.

AU - Újhelyi, E.

AU - Stoiber, H.

AU - Dierich, M. P.

AU - Susal, C.

AU - Füst, G.

PY - 1995

Y1 - 1995

N2 - Previously we have investigated the interaction of human complement as well as one polyclonal and three human monoclonal antibody preparations with the human immunodeficiency virus type-1 (HIV-1) transmembrane recombinant glycoprotein (rgp41). A strong competition was found between the antibodies and deposited complement proteins for the same binding sites located within the immunodominant region of rgp41. The aim of the present experiments was to see if the same type of antibody-complement-HIV-1 interactions could be observed with the outer envelope glycoprotein (rgp 120) of HIV-1. Three different glycosylated rgp 120 preparations, as well as a synthetic peptide corresponding to the V3 loop of the MN strain, were adsorbed to enzyme-linked immunosorbent assay (ELISA) plates and incubated with mixtures of anti-rgp120 antibodies and normal human serum (NHS) as a complement source. Fixed complement proteins and antibodies were detected with specific, peroxidase-labelled antibodies against different complement proteins (C1q, C4b, C3b) and the γ-chain of antibodies. In the absence of anti-rgp120, high amounts of C3 were deposited to each rgp120 preparation tested (including the V3 peptide) but significant differences in the amounts of bound C1q and C4b were observed. Using sera deficient in different complement proteins, we found that both the classical and the alternative pathways contributed to the C3 binding to rgp120. Addition of specific antibodies did not increase complement activation by rgp120 and only in the case of a monoclonal antibody to the V3-loop could we see complement-dependent inhibition of antibody binding.

AB - Previously we have investigated the interaction of human complement as well as one polyclonal and three human monoclonal antibody preparations with the human immunodeficiency virus type-1 (HIV-1) transmembrane recombinant glycoprotein (rgp41). A strong competition was found between the antibodies and deposited complement proteins for the same binding sites located within the immunodominant region of rgp41. The aim of the present experiments was to see if the same type of antibody-complement-HIV-1 interactions could be observed with the outer envelope glycoprotein (rgp 120) of HIV-1. Three different glycosylated rgp 120 preparations, as well as a synthetic peptide corresponding to the V3 loop of the MN strain, were adsorbed to enzyme-linked immunosorbent assay (ELISA) plates and incubated with mixtures of anti-rgp120 antibodies and normal human serum (NHS) as a complement source. Fixed complement proteins and antibodies were detected with specific, peroxidase-labelled antibodies against different complement proteins (C1q, C4b, C3b) and the γ-chain of antibodies. In the absence of anti-rgp120, high amounts of C3 were deposited to each rgp120 preparation tested (including the V3 peptide) but significant differences in the amounts of bound C1q and C4b were observed. Using sera deficient in different complement proteins, we found that both the classical and the alternative pathways contributed to the C3 binding to rgp120. Addition of specific antibodies did not increase complement activation by rgp120 and only in the case of a monoclonal antibody to the V3-loop could we see complement-dependent inhibition of antibody binding.

UR - http://www.scopus.com/inward/record.url?scp=0029044657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029044657&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 184

EP - 189

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 2

ER -